Stem Cell Transplant and Cellular Immunotherapy Program at MedStar Georgetown University Hospital

About Stem Cell Transplant and Cellular Immunotherapy Program at MedStar Georgetown University Hospital

The Stem Cell Transplant and Cellular Immunotherapy Program at MedStar Georgetown University Hospital stands as a pillar of advanced medical care in the Washington, D.C. area. As the only adult, FACT-accredited program in the region for allogeneic and autologous transplantation, as well as CAR T-cell therapy, it represents the pinnacle of excellence in stem cell and cellular immunotherapy. This accreditation signifies that the program has met the most rigorous standards in every facet of stem cell therapy, from collection and processing to patient care and clinical outcomes. The program operates under the umbrella of the Georgetown Lombardi Comprehensive Cancer Center, the only National Cancer Institute (NCI)-designated comprehensive cancer center in the Washington, D.C. region. This affiliation provides patients with unparalleled access to a robust portfolio of clinical trials and cutting-edge treatment options, ensuring that they receive the most advanced care available. The mission of the program is to provide life-saving treatment options for patients with cancers affecting the blood or immune system, as well as other complex disorders. The team of specialists possesses extensive experience in performing these intricate procedures with a focus on safety, efficacy, and patient comfort. The program is particularly adept at managing high-risk patients, offering hope to those with complex and challenging conditions. The dedicated 18-bed stem cell transplant, oncology, and hematology unit is staffed by specialty-trained nurses who provide round-the-clock expert care. The program’s holistic approach extends beyond medical treatment, with comprehensive training and support for caregivers, recognizing the vital role they play in a patient's journey.

The facilities are state-of-the-art, featuring a bright and beautifully decorated transplant clinic designed to create a healing and comfortable environment for patients and their families. The program’s commitment to excellence is further demonstrated by its collaboration with the John Theurer Cancer Center at Hackensack University Medical Center, one of the nation’s ten largest and most prestigious cancer programs. This partnership fosters a dynamic exchange of knowledge and expertise, ensuring that patients at MedStar Georgetown benefit from the latest advancements in the field. The program is also home to the nation’s largest marrow harvesting site, a testament to its leadership and expertise in the field of stem cell transplantation. The patient experience is at the forefront of the program’s philosophy. From the initial consultation to post-transplant care, the team is dedicated to providing compassionate, personalized, and comprehensive care. The program’s specialists treat a wide range of conditions, including acute and chronic leukemias, aplastic anemia, metastatic melanoma, multiple myeloma, non-Hodgkin and Hodgkin lymphoma, myelodysplastic syndromes, primary light chain amyloidosis, myeloproliferative disorders, and sickle cell anemia. The procedures performed include allogeneic stem cell transplant, autologous stem cell transplant, CAR T-cell therapy, and TIL therapy, offering a comprehensive suite of options to meet the diverse needs of their patients.

Clinic Information

Treatments Offered

Medical Team

Frequently Asked Questions